Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:33:32.183Z.
Calculation as of: 2026-10-06T17:33:32.183Z.
Quote observation: 2026-10-06T17:21:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9eb175beb73ea6d5bc2b5d4e57ff3726ad64c6dbf03440990cee379981bf6545
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Psyence Biomedical Ltd.
Market Cap
$96046.00
EV/EBIT Ratio
N/A
Market Cap
$30664.00
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Psyence Biomedical Ltd. (PBM) | $96046.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108688.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $72318.00 | N/A |
| Akanda Corp. (AKAN)vs › | $61819.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30664.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6197.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $243502.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381125.00 | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $556226.00 | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
